Pre-treatment carbohydrate antigen 19-9 does not predict the response to neoadjuvant therapy in patients with localized pancreatic cancer

首页> 外文期刊>HPB: the official journal of the International Hepato Pancreato Biliary Association >Pre-treatment carbohydrate antigen 19-9 does not predict the response to neoadjuvant therapy in patients with localized pancreatic cancer

【24h】

机译：预处理的碳水化合物抗原胜负没有预测新辅助治疗的反应本地化的胰腺癌患者

获取原文

获取原文并翻译 | 示例

页面导航

摘要

Background: The prognostic value of CA19-9 in patients with pancreatic cancer (PC) treated with neoadjuvant therapy has not been well described.

机译：背景:CA19-9的预后价值胰腺癌患者(PC)处理新辅助治疗并没有被很好的描述。

来源
《HPB: the official journal of the International Hepato Pancreato Biliary Association》 |2015年第10期|942-952|共11页
作者
Aldakkak Mohammed; Christians Kathleen K.; Krepline Ashley N.George BenRitch Paul S.Erickson Beth A.Johnston Fabian M.Evans Douglas B.Tsai Susan;
展开▼
作者单位

Med Coll Wisconsin, Dept Radiat Oncol, Pancreat Canc Program, Milwaukee, WI 53226 USA;

Med Coll Wisconsin, Dept Surg, Milwaukee, WI 53226 USA;

Med Coll Wisconsin, Dept Med, Milwaukee, WI 53226 USA;

展开▼
收录信息
原文格式 PDF
正文语种英语
中图分类
关键词
Pancreatic Neoplasms; Patients; CA-19-9 AntigenNeoadjuvant TherapyCancer of Pancreas;

机译：胰腺肿瘤;患者;CA-19-9AntigenNeoadjuvant TherapyCancer的胰腺;